Representative before the EPO

Company dna finnegan europe llp
operating since 2013
Headquarter in London and 1 office
active in Legal Services

Representative before the EPO

Employment test 51 - 200 employees
Company dna j a kemp
no operation time available
1128.02
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Hazel Ford has worked on the following 19 EPO patent applications which have been published in the last five years:

EP12187826

Specialized oligonucleotides and their use in nucleic acid amplification and detection

IPC classification:
C12Q 1/68
Agent:
Hazel Ford, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12180443

Novel neutralizing immunogen (NIMIV) of Rhinovirus and its use for vaccine applications

IPC classification:
A61K 39/12, C07K 14/005, C12N 15/00
Applicant:
Sanofi Pasteur Biologics LLC
Agent:
Hazel Ford, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11749881

TREATMENT OF LIVER CANCER

IPC classification:
A61K 31/47, A61K 31/4706, A61K 31/7088, A61P 35/00, G01N 33/50
Agent:
Hazel Ford, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11748700

TREATMENT

IPC classification:
A61K 31/00, A61K 31/417, A61K 31/4178, A61K 31/475, A61P 1/16
Applicant:
UCL Business plc
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12774207

USE OF MYELIN BASIC PROTEIN AS A NOVEL GENETIC FACTOR FOR RHEUMATOID ARTHRITIS

IPC classification:
C12N 15/09, C12Q 1/68, G01N 33/15, G01N 33/50, G01N 33/53, G01N 33/564
Applicant:
Kyoto University
Agent:
Multiple attorneys, J A Kemp
Status:
PATENT GRANTED
EP12792838

GENE TARGETING VECTOR, METHOD FOR MANUFACTURING SAME, AND METHOD FOR USING SAME

IPC classification:
C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 15/09
Applicant:
Yokohama City University
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12792225

PRODUCTION METHOD FOR ARTIFICIAL CANCER STEM CELL AND INDUCED DIFFERENTIATION METHOD THEREFOR

IPC classification:
C12N 5/10, C12N 15/09, C12Q 1/02
Applicant:
Yokohama City University
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12752901

NOVEL VITAMIN D RECEPTOR MODULATOR WITH PARTIAL AGONIST ACTIVITY

IPC classification:
A61K 31/59, A61P 3/10, A61P 9/00, A61P 17/06, A61P 19/10, A61P 25/28, A61P 31/00, A61P 35/00, A61P 37/06, A61P 43/00, C07C 401/00
Applicant:
Nihon University
Agent:
Multiple attorneys, J A Kemp
Status:
PATENT GRANTED
EP13195156

Reagents and Methods for PCR

IPC classification:
C12Q 1/68
Applicant:
Brandeis University
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11831546

METHODS OF MAKING L-ORNITHINE PHENYL ACETATE

IPC classification:
A61K 31/192, A61K 31/198, A61P 1/16, C07C 57/46, C07C 227/18, C07C 229/26
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13195355

Engineered CO2 fixing microorganisms producing carbon-based products of interest

IPC classification:
C12M 1/00, C12M 3/00
Agent:
Multiple attorneys, J A Kemp
Agent:
Hazel Ford, Finnegan Europe LLP
Status:
EXAMINATION IN PROGRESS
EP12813711

E-SELECTIN ANTAGONIST COMPOUNDS, COMPOSITIONS, AND METHODS OF USE

IPC classification:
A61K 31/7034, A61P 35/00, C07H 15/207
Agent:
Hazel Ford, Finnegan Europe LLP
Status:
GRANT OF PATENT INTENDED
EP12818038

TECHNIQUE FOR CLEAVING OUT PART OF poly(A) CHAIN AND/OR 3'-TERMINAL SEQUENCE OF mRNA TO INHIBIT TRANSLATION REACTION

IPC classification:
A01K 67/027, A61K 31/7105, A61K 31/713, A61K 48/00, A61P 25/00, A61P 35/00, A61P 37/08, C12N 5/10, C12N 15/09
Applicant:
Tokyo Institute of Technology
Applicant:
Yokohama City University
Agent:
Multiple attorneys, J A Kemp
Status:
APPLICATION WITHDRAWN
EP11748969

TREATMENT

IPC classification:
A61K 31/00, A61K 38/04, A61P 1/16, A61P 13/12
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11825257

MODEL ANIMAL FOR STUDYING HAIR GROWTH CYCLE

IPC classification:
A01K 67/027, C12N 15/09, G01N 33/50
Applicant:
National Institute of Advanced Industrial Science and Technology
Agent:
Multiple attorneys, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12182252

ENA nucleic acid drugs modifying splicing in mRNA precursor

IPC classification:
A61K 31/7088, A61K 31/712, A61K 31/7125, A61K 48/00, A61P 21/04, C07H 21/04, C12N 15/11
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Applicant:
Kobe Gakuin University
Applicant:
Kobe University
Agent:
Multiple attorneys, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12182257

ENA nucleic acid drugs modifying splicing in mRNA precursor

IPC classification:
A61K 31/7088, A61K 31/712, A61K 31/7125, A61K 48/00, A61P 21/04, C07H 21/04, C12N 15/11
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Applicant:
Kobe Gakuin University
Applicant:
Kobe University
Agent:
Multiple attorneys, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12182258

ENA nucleic acid drugs modifying splicing in mRNA precursor

IPC classification:
A61K 31/7088, A61K 31/712, A61K 31/7125, A61K 48/00, A61P 21/04, C07H 21/04, C12N 15/11
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Applicant:
Kobe Gakuin University
Applicant:
Kobe University
Agent:
Multiple attorneys, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12182249

ENA nucleic acid drugs modifying splicing in mRNA precursor

IPC classification:
A61K 31/7088, A61K 31/712, A61K 31/7125, A61K 48/00, A61P 21/04, C07H 21/04, C12N 15/11
Applicant:
Daiichi Sankyo Company, Limited (Daiichi Sankyō Kabushiki-kaisha)
Applicant:
Kobe Gakuin University
Applicant:
Kobe University
Agent:
Multiple attorneys, J A Kemp
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature